Studying c-Myc serine 62 phosphorylation in leukemia cells: concern over antibody cross-reactivity

Authors:

Abstract
To the editor: A recent article in Blood demonstrated that the Pim kinase inhibitor SGI-1776 has efficacy in acute myeloid leukemia.[1][1] This inhibitor reduced phosphorylation of multiple targets of the Pim kinases, including c-Myc at serine 62 (S62). Because no therapies directly target c-Myc,